A Study of the Safety and Pharmacokinetics of BRCX014 in Patients With Glioblastoma
Status:
Unknown status
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
An Open-Label, Multi-Center Study to Assess the Safety and Pharmacokinetics of BRCX014
Combined with Standard-of-Care Treatment in Subjects with Glioblastoma